Ocrelizumab is associated with increased risks for infection and hospitalization among older adults with multiple sclerosis, ...

If ongoing studies demonstrate favorable safety and efficacy profiles, CAR T-cell therapy may establish a novel treatment ...

Multiancestry genome-wide association analyses of multiple sclerosis integrated with single-cell, single-nucleus and spatial transcriptomics data yield insights into the cellular, spatial and temporal ...

Hollywood actress Christina Applegate opened up about spending life with multiple sclerosis , a chronic neurological ...

A new meta-analysis of thirteen randomized controlled trials finds that vestibular rehabilitation improves balance, gait, ...

BRIUMVI was associated with a lower risk of 24-week confirmed disability progression (CDP24) compared with both ocrelizumab and ofatumumab, with a 44% lower relative hazard versus ocrelizumab (HR ...

The National MS Society launched a 'Campaign to End MS,' aiming to raise $1 billion for research and to improve access to ...

Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company advancing ...

A Journal of Neurology case report describes severe invasive pneumococcal pneumonia after influenza A in a multiple sclerosis ...

Multiple sclerosis is a chronic disease where your immune system starts attacking your brain and spinal cord. The number of people living with the condition has grown to 913,925—current estimates ...

Multiple sclerosis occurs when a person’s immune system is triggered to attack the myelin sheath—a protective coating surrounding nerve cells in the central nervous system (CNS). The CNS is made up of ...

Multiple Sclerosis (MS) imposes a significant psychological burden that adversely affects patients’ subjective well-being (SWB). A primary psychological stressor in this population is the Fear of ...